Shopping Cart
- Remove All
- Your shopping cart is currently empty
Livmoniplimab (ABBV-151; ARGX-115), a potent humanized monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, inhibits LRRC32-mediated activation of latent TGFβ1, showing promise for cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $257 | 2-4 weeks | |
5 mg | $668 | 2-4 weeks | |
10 mg | $1,070 | 2-4 weeks |
Description | Livmoniplimab (ABBV-151; ARGX-115), a potent humanized monoclonal antibody targeting LRRC32 (GARP)/TGFβ1, inhibits LRRC32-mediated activation of latent TGFβ1, showing promise for cancer research [1]. |
Cas No. | 2412004-88-5 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.